Celldex's pipeline is comprised of therapeutic antibodies, antibody drug conjugates (ADCs), immune system modulators and other protein-based therapeutics that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications.

Celldex-Sponsored Studies

Third-Party Sponsored Studies